Remember the Pitfall: Intrapancreatic Accessory Spleen Mimicking Neuroendocrine Neoplasm.

We report of a 71-year-old woman with a 2-cm somatostatin receptor-positive intrapancreatic lesion almost misdiagnosed as neuroendocrine neoplasm. By additional red blood cell scintigraphy with heat-damaged erythrocytes, the lesion was identified as an intrapancreatic accessory spleen, and unnecessary operation (which was already planned) could be avoided. This case report reminds colleagues to consider accessory spleen as differential diagnosis for somatostatin receptor-positive lesions even when located inside the pancreas. In doubtful cases, a scintigraphy with heat-damaged erythrocytes is a very useful and complementary imaging method and should be performed before any planning of surgery.

[1]  J. E. Gonçalves,et al.  Intrapancreatic accessory spleen , 2017, Einstein.

[2]  J. Serrano-Vicente,et al.  Pancreatic accessory spleen. False positive with 99mTc-Octreotide. , 2017, Revista espanola de medicina nuclear e imagen molecular.

[3]  T. Winkens,et al.  Splenic scintigraphy for further differentiation of unclear 68Ga‐DOTATOC‐PET/CT findings: Strengths and limitations , 2016, Journal of medical imaging and radiation oncology.

[4]  A. G. García Vicente,et al.  Role of 99mTc-HYNIC-Tyr3-octreotide scintigraphy in neuroendocrine tumors based on localization of the primary tumor. , 2016, Minerva endocrinologica.

[5]  A. Ferreira,et al.  Intrapancreatic accessory spleen: a misleading diagnosis , 2013, BMJ Case Reports.

[6]  B. Sawan,et al.  Case note: intrapancreatic accessory spleen mimicking a pancreatic endocrine tumour. , 2010, Canadian journal of surgery. Journal canadien de chirurgie.

[7]  M. Tei,et al.  Intrapancreatic accessory spleen diagnosed by technetium-99m heat-damaged red blood cell SPECT. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  F. Gyorkey,et al.  Lesions observed in accessory spleens of 311 patients. , 1959, American journal of clinical pathology.